KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.00
-0.02 (-1.96%)
At close: 3:53PM EDT
Stock chart is not supported by your current browser
Previous Close1.02
Open1.03
Bid0.99 x 0
Ask1.00 x 0
Day's Range0.97 - 1.05
52 Week Range0.97 - 1.43
Volume277,375
Avg. Volume398,915
Market Cap46.852M
Beta0.17
PE Ratio (TTM)N/A
EPS (TTM)-0.21
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group2 days ago

    IIROC Trading Resumption - KHRN

    VANCOUVER , July 17, 2018 /CNW/ - Trading resumes in: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Resumption (ET): 11:30 IIROC can make a decision to impose a temporary suspension (halt) ...

  • CNW Group2 days ago

    Khiron Appoints Former Mexican President Vicente Fox to Board of Directors

    TORONTO, July 17, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has appointed former President of Mexico Mr. Vicente Fox Quesada to its board of directors, effective immediately. Mr. Fox will be a strategic advisor and brand ambassador for the Company, furthering the Company's education and brand leadership interests across Latin America.

  • CNW Group3 days ago

    IIROC Trading Halt - KHRN

    VANCOUVER , July 16, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Reason: At the Request of the Company Pending News Halt Time ...

  • CNW Group14 days ago

    Khiron Life Sciences Expands CBD-Based Wellness Product Portfolio With Additional Authorizations from Colombian National Food and Drug Surveillance Institute (INVIMA)

    TORONTO , July 5, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia ...

  • CNW Group23 days ago

    Khiron Expands Leadership Team with Appointment of Chris Naprawa as President

    TORONTO, June 26, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the appointment of Chris Naprawa as President, effective immediately. Mr. Naprawa, who will report to Alvaro Torres, CEO, will lead Khiron's capital markets activities, including outreach to existing and potential shareholders in Canada and internationally.

  • CNW Group24 days ago

    Khiron Appoints Internationally Recognized Medical Cannabis Specialist Dr. Maria Fernanda Arboleda as Medical Director

    TORONTO, June 25, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that it has appointed Dr. Maria Fernanda Arboleda as Medical Director.

  • GlobeNewswire27 days ago

    Grit Capital launches GritCAMP Immersive Investment Conference in Muskoka July 25-27th 2018

    Grit Updates the Market on Recent Corporate Initiatives & Milestones. TORONTO, June 22, 2018-- GRIT CAPITAL INC. a capital markets advisory firm known for its aggressive“ out of the box” thinking to capture ...

  • CNW Group28 days ago

    Khiron Life Sciences Corp. Applauds Election of Iván Duque as President of Colombia

    TORONTO, June 21, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, wishes to congratulate President-Elect, Iván Duque of the Democratic Centre party, on winning the election on June 17, 2018 to become the next federal leader of Colombia. Mr. Duque will take over from incumbent President Juan Manuel Santos in August.

  • CNW Grouplast month

    Khiron VP, Compliance Matt Murphy Appears on CBS Network's 60 Minutes to Discuss Law Enforcement and the Global Opioid Crisis

    TORONTO, June 19, 2018 /CNW/ - Khiron Life Sciences Corp. (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that its newly appointed Vice President of Compliance, Matt Murphy, appeared on CBS Network's June 17, 2018 airing of 60 Minutes to discuss important aspects of the U.S. opioid crisis. Murphy and other senior U.S. Drug Enforcement Administration (DEA) agents revealed in the program detailed investigative accounts that expose a failure by the U.S. pharmaceutical industry to regulate itself and stem the massive flow of opioid-based painkillers into the consumer marketplace.

  • CNW Grouplast month

    Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients

    TORONTO, June 14, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has formed an exclusive strategic alliance with Latin American Institute of Neurology and the Nervous System ("ILANS"), one of the most respected, fastest growing, and largest health service provider networks in Colombia and Latin America. ILANS represents an estimated 100,000 patients, with the majority of these patients being located in Colombia.

  • CNW Grouplast month

    Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia

    Colombian Agricultural Institute ("ICA") authorization is a significant requirement to cultivate and distribute medical cannabis in Colombia. TORONTO, June 13, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has been registered by the Colombian Agricultural Institute ("ICA") as an agronomical unit.

  • Baystreetlast month

    Stocks in play: Khiron Life Sciences Corp.

    Has received endorsements and signed co-operation agreements with two of the largest and most recognized ...

  • Khiron Life Sciences Corp. Opens the Market
    CNW Grouplast month

    Khiron Life Sciences Corp. Opens the Market

    TORONTO , June 11, 2018 /CNW/ - Alvaro Torres , CEO, Khiron Life Sciences Corp. (KHRN), joined Richard Rohan , VP, Global Sales, Capital Formation, TMX Group, to open the market. Khiron is a Canadian integrated ...

  • CNW Grouplast month

    Khiron Secures Medical Cannabis Endorsements from Two of the Largest Medical Associations in Colombia

    TORONTO, June 11, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that it has received endorsements and signed co-operation agreements with two of the largest and most recognized medical associations in the country: The Colombian Association of Internal Medicine (ACMI) and the Colombian Association of Neurology (ACN). As a result, Khiron becomes the first medical cannabis company in Colombia to be endorsed by two medical associations and to be in a position to directly introduce its brand to a national audience of almost 3,000 doctors.

  • CNW Grouplast month

    Khiron to Open TSX Venture Exchange and Host Media Interviews on June 11, 2018

    TORONTO, June 8, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, will open the market of the TSX Venture Exchange on Monday, June 11, 2018 at 9:30 a.m. EDT. Khiron, as the first cannabis company with active operations in Colombia to list on any exchange globally, will be meeting with members of media after the market opens. Khiron has positioned itself as the leading medical cannabis company in Latin America.

  • CNW Group2 months ago

    KCSA Strategic Communications Announces June 7th Cannabis Virtual Investor Conference

    NEW YORK , May 31, 2018 /CNW/ --  KCSA Strategic Communications , an integrated public relations, media relations, social media, and investor relations agency, today announced its Virtual Investor Conference ...

  • CNW Group2 months ago

    Khiron Appoints Former DEA Chief of Pharmaceutical Investigations Matt Murphy as Vice President, Compliance

    TORONTO, May 31, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that it has appointed former U.S. Drug Enforcement Administration ("DEA"), Chief of Pharmaceutical Investigations, Matt Murphy, as the Company's Vice President, Compliance.

  • CNW Group2 months ago

    Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export

    TORONTO, May 30, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that The Colombia National Food and Drug Surveillance Institute ("INVIMA"), a level four World Health Organization ("WHO") agency, has granted Khiron authorization for the production, sale and export of four cannabidiol ("CBD") based products.

  • Khiron Strategically Positioned to Enter Mexican Medical Cannabis Market
    CNW Group2 months ago

    Khiron Strategically Positioned to Enter Mexican Medical Cannabis Market

    TORONTO, May 29, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the Company is strategically positioned to enter the medical cannabis market in Mexico by acting as a key sponsor of the CannaMexico World Summit. The conference will be hosted by former Mexican President, Vicente Fox Quesada, a leading advocate for medical cannabis as an alternative treatment method for a wide range of medical conditions. The opportunity to exchange information with medical professionals alongside former President Fox, represents a core element of Khiron's market strategy of education and sharing of experiences across borders in Latin America.